Abstract:Objective To evaluate the effect of increased contact force ablation in patients with atrioventricular nodal reentrant tachycardia (AVNRT) after unsuccessful routine procedure. Methods Five retrospective cases (no evidence of organic heart disease) admitted in Characteristic Medical Center of Chinese People's Armed Police Force between October 2017 and April 2021 were enrolled. Through Carto-3 system, the patients underwent ablation according to conventional method. After continuous junction rhythm appeared which meant the effective ablation endpoint, AVNRT could still be induced. Increased contact force was applied upon the first-time marked ablated point sequentially and the tachycardia was triggered repeatedly. Continuous radiofrequency ablation was performed at the non-induced point. Results Successful ablation was achieved in all 5 cases and the mean procedure time was (9.4±2.4) min. Tachycardia could not be induced at mean contact force of (15.4±2.2) g. Maximal contact force of ablation was (10.4±2.3) g, which was significantly higher than that of routine method [(5.8±1.6) g, P<0.01]. The cumulative radiofrequency time was (68.6±8.5) s and no serious complications occurred. No recurrence of tachycardia occurred at mean (18.6±14.4) months follow-up. Conclusions Increased contact force ablation is simple, safe and effective in treating refractory AVNRT when conventional ablation fails.
Markowitz S M, Lerman B B. A contemporary view of atrioventricular nodal physiology [J]. J Interv Card Electrophysiol, 2018, 52(3):271-279.
[2]
Mani B C,Pavri B B. Dual atrioventricular nodal pathways physiology: a review of relevant anatomy, electrophysiology and electrocardiographic manifestations[J].Indian Pacing Electrophysiol J, 2014,14(1): 12-25.
[3]
Hollanda L, Sobral R, Luize C, et al. Atrioventricular nodal reentrant tachycardia and the dilemma of reentry circuit components: a proof of concept[J]. Heart Rhythm Case Rep, 2021, 7(7):439-441.
[4]
Katritsis D G,Josephson M E. Classification, electrophysiological features and therapy of atrioventricular nodal reentrant tachycardia[J].Arrhythm Electrophysiol Rev, 2016, 5(2) : 130-135.
[5]
Bearl D W, Mill L, Kugler J D,et al. Visualization of atrioventricular nodal reentry tachycardia slow pathways using voltage mapping for pediatric catheter ablation [J].Congenit Heart Dis, 2015, 10 (4) : E172-E179.
[6]
Katritsis D G, Marine J E, Katritsis G, et al.Spatial characterization of the tachycardia circuit of atrioventricular nodal re-entrant tachycardia [J]. Europace, 2021, 23(10): 1596-1602.
Katritsis D G,Marine J E,Contreras F M, et al.Catheter ablation of atypical atrioventricular nodal reentrant tachycardia[J]. Circulation, 2016, 134(21): 1655-1663.
[9]
Wang N C. Catheter ablation via the left atrium for atrioventricular nodal reentrant tachycardia: a narrative review [J]. Heart Rhythm, 2021,2(2):187-200.
[10]
Vaidya V R. Catheter ablation for atrioventricular nodal reentrant tachycardia: when all is not right, ablate what is left [J]. Indian Pacing Electrophysiol J, 2021, 21(1):11-13.
[11]
Kaneko Y, Naito S, Okishige K, et al. Atypical fast-slow atrioventricular nodal reentrant tachycardia incorporating a “Superior” slow pathway: a distinct supraventricular tachyarrhythmia [J]. Circulation, 2016, 133(2): 114-123.
[12]
Kaneko Y, Nakajima T, Tamura S, et al. Superior-type fast-slow atrioventricular nodal reentrant tachycardia phenotype mimicking the slow-fast type[J].Circ Arrhythm Electrophysiol, 2020, 13(11): e008732.
[13]
Chua K, Upadhyay G A, Lee E, et al. High-resolution mapping of the triangle of koch: spatial heterogeneity of fast pathway atrionodal connections [J]. Heart Rhythm, 2018, 15(3):421-429.
[14]
Parwani A S, Hohendanner F, Bode D, et al. The force stability of tissue contact and lesion size index during radiofrequency ablation: an ex-vivo study [J]. Pacing Clin Electrophysiol, 2020,43(3):327-331.
[15]
Jiang J B, Li J Y, Jiang Z Y, et al. Impact of catheter-tissue contact force on lesion size during right ventricular outflow tract ablation in a swine mode [J]. Chin Med J (Engl), 2020, 133(14): 1680-1687.